Arogyavardhini Vati – Critical Analysis of a Miracle Drug
Keywords:
Arogyavardhini vati, Multipurpose action, Rasapanchaka analysisAbstract
Introduction: Arogyavardhini Vati is a herbomineral preparation which has miraculous effects on many diseases. It has the ability of balancing Tridosha and is beneficial in many liver disorders, dyslipidemia, metabolic syndrome, skin diseases, etc. Many clinical research and animal studies have been done to establish its actions in various diseases and its safety during use. Material and Methods: Here, in this article, an attempt is made to collect all the literary data about Arogyavardhini Vati from our treaties and all the research articles available. These data are compiled and analyzed and the results obtained are presented. Results: The Rasapanchaka analysis shows that Arogyavardhini Vati is Tikta Rasa Pradhana (27.59%) followed by Kashaya (24.14%) and Katu (20.69%) rasa, predominant in Laghu (29.03%) and Ruksha Guna (29.03%), Ushna Virya predominant (54.55%), and the Vipaka was katu (54.55%). Discussion: Research evidence shows that Arogyavardhini Vati is effective on various liver diseases such as hepatitis, non-alcoholic and alcoholic fatty liver, Jalodara or ascites due to liver disorder, and autoimmune liver disease. Animal experiments also proved its hepatoprotective activities. It has anti-hyperlipidemic action, helps in metabolic syndrome, and is beneficial in many skin diseases. It reduces the pus discharge in karna srava or chronic suppurative otitis media. Studies show that pharmaceutical and analytical parameters for Arogyavardhini Vati are validated by HPTLC method. Toxicity studies show no accumulation or toxic effect of mercury and copper on vital organs. Conclusion: Arogyavardhini vati is safe and miraculously effective in many diseases.
Downloads
References
Sarashetti RS. Screening of free radical scavenging activity of Arogyavardhini Vati. Int J Res Ayurveda Pharm 2013;4:555-9. 2. Shastri AD, editor. Rasaratna Samuchchya of Vagbhata. 9th ed., Ch. 20. Verse 87. Varanasi: Chaukhamba Sanskrit Publisher; 1994. p. 400. 3. Mishra SN, editor. Siddhipada Commentary on Bhaisajyaratnavali of Govinda Das Sen, Kustharogadhikara. 1st ed., Ch. 54. Verse 117. Varanasi: Chaukhamba Surbharati Prakashana; 2012. p. 871. 4. Jamadagni S, Jamadagni P, Angom B, Mondal D, Upadhyay S, Gaidhani S, et al. Tissue distribution of mercury and copper after Aarogyavardhini Vati treatment in rat model of CCl4 induced chronic hepatotoxicity. J Ayurveda Integr Med 2020;11:508-14.
Dighde PK. Pharmaco- therapeutic efficacy of arogyavardhini vati on mahastrotas (GIT). World J Pharm Res 2020;9:493-503. 6. Pal S, Ramamurthy A, Mahajon B. Arogyavardhini Vati: A theoritical analysis. J Sci Innov Res 2016;5:225-7.
Antarkar DS, Vaidya AB, Doshi JC, Athavale AV, Vinchoo KS, Natekar MR, et al. Adouble-blind clinical trial of Arogyawardhani- an ayurvedic drug-in acute viral hepatitis. Indian J Med Res 1980;72:588-93.
Zanwar AC, Wajpeyi SM. Management of hepatitis B (Carrier stage) through ayurved - a case report. Int J Ayurvedic Med 2019;10:342-4. 9. Panda AK, Das D, Dixit AK, Giri R, Hazra J. Effect of arogyavardhini vati & phalatrikadi kwatha in non-alcoholic fatty liver diseases. Int J Adv Case Rep 2016;3:59-62.
Patil M. The efficacy of arogyavardhini vati in alcoholic fatty liver - a clinical study. World J Pharm Pharm Sci 2017;6:353-7.
Ratha KK. Ayurveda management of alcoholic liver disease with acute hepatitis B: A case report. J Ayurveda Case Rep 2020;3:143-7. 12. Sahoo SK, Prajapati AK, Sahoo J, Ranjan SK. Successful ayurvedic management of alcoholic liver disease: A case report. Sch Int J Anat Physiol 2021;4:96-100.
Panda AK. Survival Outcome in the Patients with Advanced Hepatocelluar Carcinoma Treated with Ayurveda Medication: Case Series. In: Proceeding of 7th World Ayurveda Congress, Kolkota; 2016.
Kumar AK, Bhuyan G, Dattatray D, Rao MM. Phyto extracts of Carica papaya and Tinospora cordifolia can correct thrombocytopenia in alcoholic decompensate liver cirrhosis: Case series. J Ayurveda Integr Med Sci 2018;3:1-4.
Patil SS. Ayurvedic management of Jalodara with special reference to Ascites: A case study. World J Adv Res Rev 2022;16:1048-53. 16. Panda AK. Successful treatment of vabhava satmya Virparyaya
Yakrit Kshaya (Autoimmune liver cirrhosis): A case study. Int Res J Ayurveda Yoga 2020;3:106-20.
Bhagyalaxmi KS, Deshpande S, Goud KM. An ayurvedic approach for ascites- a case study. Int Ayurvedic Med J 2016;7:90-2. 18. Sapkota YR, Bedarkar P, Nariya MB, Prajapati PK. Hepatoprotective evaluation of Arogyavardhini Rasa against paracetamol- induced liver damage in rats. BLDE University. J Health Sci 2017;2:44-9. 19. Rajkumar V. Antioxidant and anti-neoplastic activities of Picrorhiza kurroa extracts. Food Chem Toxicol 2011;49:363-9.
Girish C, Pradhan SC. Hepatoprotective activities of picroliv, curcumin, andellagic acid compared to silymarin on carbon-tetrachlorideinduced liver toxicity in mice. J Pharmacol Pharmacother 2012;3:149-55.
Kumar G. The hypolipidemic activity of Ayurvedic medicine, Arogyavardhini vati in Triton WR-1339-induced hyperlipidemic rats: A comparison with fenofibrate. J Ayurveda Integr Med 2013;4:165- 70.
Rajaratnam M, Prystupa A, Lachowska-Kotowska P, Załuska W, Filip R. Herbal medicine for treatment and prevention of liver
diseases. J Pre Clin Clin Res 2014;8:55-60.
Cabana VG, Siegel JN, Sabesin SM. Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins. J Lipid Res 1989;30:39-49.
Pepys MB, Hirschfield GM. C-reactive protein: A critical update. J Clin Invest 2003;111:1805-12.
Kumar G, Srivastava A, Sharma SK, Gupta YK. Safety and efficacy evaluation of Ayurvedic treatment (Arjuna powder and Arogyavardhini Vati) in dyslipidemia patients: A pilot prospective cohort clinical study. Ayu 2012;33:197-201.
Padhar BC, Dave AR, Goyal M. Clinical study of Arogyavardhini compound and lifestyle modification in management of metabolic syndrome: Adouble-blind placebo controlled randomized clinical trial. Ayu 2019;40:171-8.
Ghadigaonkar DD, Chawda MB, Thakur KS, Kushwah PK. Evaluation hypolipidemic activity of arogyavardhini and Zpter tablet in cholesterol-rich high fat diet (HFD) induced hyperlipidemia in wistar rats. Int J Pharm Pharm Sci 2019;11:1-5.
Ambhore KP, Wajpeyi SD. Comparative study of Lodhradi Lepa with and without Arogyavardhini Vati in the management of Yuvanpidika. J Indian Sys Med 2020;8:21-8.
Prajkta S. Ayurvedic management of shwitra: A single case study. Ayurlog Natl J Res Ayurved Sci 2021;9:1-7.
Varsakiya J, Kathad D, Kumari R. Efficiency of Ayurveda modalities in the management of Switra (Vitiligo): A case report. J Ayurveda Case Rep 2020;3:153-7.
Jadhav DK. A case study on ayurvedic management of Dadru W.S.R. to tinea cruris. J Ayurvedic Herb Integr Med 2020;1:8-12. 32. Gabhane SM, Waghmare S, Andhare R, Uke P. Ayurvedic management of vipadika kushtha (palmoplantar psoriasis) - a single case study. Int J Cur Res Rev 2021;13:171-5.
Choudhary P, Sevatkar B, Sharma S, Godatwar PK. Management of dermatological manifestation of PCOS by Pathadi and Kanchnaradi kwatha along with Arogyavardhini vati. Asian J Pharm Res 2020;10:17-22.
Rakesh RS, Ajit SV, Preeti M. Efficacy of Arogyavardhini vati and prakshalan of kshirivriksha in karnasrava. Int J Ayurvedic Med 2013;4:405-11.
Ingle A. Karnasrava (Chronic suppurative otitis media) and its management through ayurveda - a case study. World J Pharm Res 2020;9:1016-21.
Varnale GS. Role of efficacy of Arogyavardhini vati in gastrointestinal disorders. World J Pharm Med Res 2022;8:107-9.
Kotadiya R. A theoritical review on arogyavardhini vati. AYURPUB. com International Ayurveda Publications. 2022;7:2019-25. 38. Kumar S, Kumar R, Dash R, Paras K, Singh V. Ayurvedic management of hypertension. J Ayurveda Integr Med Sci 2022;5:146-9. 39. Sapkota YR, Bedarkar P, Shukla VJ, Prajapati PK. Quality control parameters of Arogyavardhini rasa prepared by classical method. J Ayu Herb Med 2016;2:104-11.
Padmaja D, Maheshwar T, Anuradha D. Pharmaceutical standardization and physicochemical analysis of arogyavardhini vati. Int J Ayurveda Pharma Res 2022;10:54-61.
Ranjana L, Raman B, Sarang D, Tarun P. Preparation and evaluation of herbo-mineral drug: Arogyavardhini Vati (Tablet). Int J Ayurveda Pharma Res 2017;5:74-6.
Kumar G, Srivastava A, Sharma SK, Gupta YK. Safety evaluation of an ayurvedic medicine, arogyavardhini vati on brain, liver and kidney in rats. J Ethnopharmacol 2012;140:151-60.
Mahajon B, Ota S, Khanduri S, Sharma BS, Kumar S, Srikanth N. Safety profile of Ayurveda Rasoushadhi: An appraisal of technical reports on quality and safety of selected Rasakalpa- Metal and mineral based Ayurvedic formulations. J Drug Res Ayurvedic Sci 2022;7:221-8.
Gupta YK. Effect of Traditionally used Ayurvedic Rasa Aushadhies
Sahoo, et al.: Arogyavardhini Vati – A Miracle Drug 2024; 7(1):86-96 93
on Renal and Hepatic Functions: Clinical and Experimental Study. All India Institute of Medical Sciences, New Delhi; 2014. Available from: https://ayushportal.nic.in/emr/clinical_final_report-5.pdf [Last accessed on 2023 Nov 11].
Deswal M, Deswal P, Laura JS. Study on some heavy metal intake through the recommended medication dosage of some ayurvedic herbs and formulations. Int J Curr Res 2016;8:43465-8.
Acharya JT, editor. Ayurveda Dipika Commentary of Chakrapanidatta on Charak Samhita of Agnivesha. Sutrasthan, Atreyabhadrakapiya
Adhyaya. 2nd ed., Ch. 26. Verse 43. Bombay: Nirnaya Sagar Press; 1935. p. 143-5.
